111
Views
0
CrossRef citations to date
0
Altmetric
News & Views from the Biological Stain Commission

Accomplishments of the Trustees and laboratory staff of the Biological Stain Commission, 2002–2013

Pages 470-479 | Accepted 02 Jan 2014, Published online: 25 Mar 2014

References

  • Anon (2009). Special symposium. Biotech. & Histochem. 84: 121.
  • Bell WC, Myers RB, Hosein TO, Oelschlager DK, Grizzle WE (2003). The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP. Biotech. & Histochem. 78: 11–16.
  • Bell WC, Young ES, Billings PE, Grizzle WE (2008). The efficient operation of the surgical pathology gross room. Biotech. & Histochem. 83: 71–82.
  • Boyce BF (2012). Optimizing the use and applications of special stains: clinical and experimental approaches. Biotech. & Histochem. 87: 1–2.
  • Chhieng DC, Frost AR, Niwas S, Weiss H, Grizzle WE, Beeken S (2004). Intra-tumor heterogeneity of biomarker expression in breast carcinomas. Biotech. & Histochem. 79: 25–36.
  • Clark G (1974). A history of quality assurance in biological dyes. Am. Soc. Microbiol. News 40: 252–259.
  • Colston J, Horobin RW, Rashid-Doubell F, Pediani J, Johal KK (2003). Why fluorescent probes for endoplasmic reticulum are selective: an experimental and QSAR-modelling study. Biotech. & Histochem. 78: 323–332.
  • Conn HJ (1980a). The history of the Stain Commission. Stain Technol. 55: 269–279.
  • Conn HJ (1980b). The history of the Stain Commission. II. Organization. Stain Technol. 55: 327–352.
  • Conn HJ (1981a). The history of the Stain Commission. III. Birth of the Stain Commission. Stain Technol. 56: 1–17.
  • Conn HJ (1981b). The history of the Stain Commission. IV. Expansion of the work. Stain Technol. 56: 59–66.
  • Conn HJ (1981c). The history of the Stain Commission: V. War and its consequences. Stain Technol. 56: 135–142.
  • Dapson JC (2012). Biological Stain Commission News. Biotech. & Histochem. 87: 66–67.
  • Dapson JC, Dapson RW (2005). Hazardous Chemicals in the Histopathology Laboratory: Regulations, Risks, Handling and Disposal. Anatech Ltd., Battle Creek, MI.
  • Dapson RW (1993). Fixation for the 1990’s: a review of needs and accomplishments. Biotech. & Histochem. 68: 75–82.
  • Dapson RW (2005a). A method for determining identity and relative purity of carmine, carminic acid and aminocarminic acid. Biotech & Histochem. 80: 201–205.
  • Dapson RW (2005b). Dye-tissue interactions: mechanisms, quantification and bonding parameters for dyes used in biological staining. Biotech. & Histochem. 80: 49–72.
  • Dapson RW (2007a). Effects of fixation on routine, special and immunohistochemical stains: introduction to a symposium for the Biological Stain Commission. Biotech. & Histochem. 82: 131–132.
  • Dapson RW (2007b). Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech. & Histochem. 82: 133–140.
  • Dapson RW (2007c). Glyoxal fixation: how it works and why it only occasionally needs antigen retrieval. Biotech. & Histochem. 82: 161–166.
  • Dapson RW (2007d). The history, chemistry and modes of action of carmine and related dyes. Biotech. & Histochem. 82: 173–187.
  • Dapson RW (2009). Benzidine-based dyes: effects of industrial practices, regulations, and world trade on the biological stains market. Biotech. & Histochem. 84: 95–100.
  • Dapson RW (2010). Mechanisms of action and proper use of common fixatives. In: Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. John Wiley & Sons, Inc., Hoboken, NJ. pp. 195–217.
  • Dapson RW (2013). Alternative methods for estimating common descriptors for QSAR studies of dyes and fluorescent probes using molecular modeling software: 1. Concepts and procedures.Biotech. & Histochem. 88: 477–488.
  • Dapson RW, Horobin RW (2009). Dyes from a twenty-first century perspective. Biotech. & Histochem. 84: 135–137.
  • Dapson RW, Horobin RW (2013a). Biological Stain Commission symposium, 2012: fluorochromes. Biotech. & Histochem. 88:426–427.
  • Dapson RW, Horobin RW (2013b). Alternative methods for estimating common descriptors for QSAR studies of dyes and fluorescent probes using molecular modeling software. 2. Correlations between log P and the hydrophilic/lipophilic index, and new methods for estimating degrees of amphiphilicity. Biotech. & Histochem. 88: 489.497.
  • Dapson RW, Frank M, Penney DP Kiernan JA (2007). Revised procedures for the certification of carmine (C.I. 75470, natural red 4) as a biological stain. Biotech. & Histochem. 82: 13–15.
  • Dapson RW, Horobin RW, Kiernan JA (2010). Hematoxylin shortages: their causes and duration, and other dyes that can replace hemalum in routine hematoxylin and eosin staining. Biotech. & Histochem. 85: 55–63.
  • Dapson RW, Fagan C, Kiernan JA, Wickersham TW (2011). Certification procedures for Sirius red F3B (CI 35780, direct red 80). Biotech. & Histochem. 86: 133–139.
  • Del Castillo P, Horobin RW, Blazquez-Castro A, Stockert JC (2010). Binding of cationic dyes to DNA: distinguishing intercalation and groove binding mechanisms using simple experimental and numerical models. Biotech. & Histochem. 85: 247–256.
  • Fagan CL (2012). The Biological Stain Commission’s Quality Control Laboratory operations and improved traceability of certified stains. Biotech. & Histochem. 87: 10–13.
  • Floyd AD (2010). Image analysis in immunohistochemistry. In: Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. John Wiley & Sons, Inc., Hoboken, NJ. pp. 165–185.
  • Frank M, Dapson RW, Wickersham TW, Kiernan JA (2007). Certification procedures for nuclear fast red (Kernechtrot), CI 60760. Biotech. & Histochem. 82: 35–39.
  • Frederick PJ, Green HN, Huang JS, Egger ME, Frieboes, Grizzle WE, McNally LR (2013). Chemoresistance in ovarian cancer linked to expression of microRNAs. Histochemistry 88: 403–409.
  • Grizzle WE (1996). Theory and practice of silver staining in histopathology. J. Histotechnol. 19: 183–195.
  • Grizzle WE (2009). Special symposium: fixation and tissue processing models. Biotech. & Histochem. 84: 185–193.
  • Grizzle WE (2013). It is primarily the control of transcription and post-transcriptional processing that are critical to the development and progression of sporadic neoplasias. Biotech. & Histochem. 88: 361–364.
  • Hicks DG, Boyce BF (2012). The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research. Biotech. & Histochem. 87: 14–17.
  • Hicks DG, McMahon L (2010). The pros and cons of automation for immunohistochemistry from the prospective of the pathology laboratory.In: Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. John Wiley & Sons, Inc., Hoboken, NJ. pp. 151–163.
  • Hicks DG, Whitney-Miller (2013). The evolving role of HER2 evaluation for diagnosis and clinical decision making for breast and gastric adenocarcinoma. Biotech. & Histochem. 88: 121–131.
  • Hope-Roberts M, Horobin RW (2012). Biomedical applications and chemical nature of three dyes first synthesized by Raphael Meldola: isamine blue, Meldola’s blue and naphthol green B. Biotech. & Histochem. 87: 295–299.
  • Hope-Roberts M, Wainwright M, Horobin R (2008). A nitobenzofuran-conjugated phosphatidylcholine (C12-NBD-PC) as a stain for membrane lamellae for both microscopic imaging and spectrofluorometry. Biotech. & Histochem. 83: 25–28.
  • Hope-Roberts M, Horobin RW, Wainwright M (2011). Identifying apoptotic cells with the 3-hydroxyflavone derivative F2N12S, a ratiometric fluorescent small molecule probe selective for plasma membranes: a possible general mechanism for selective uptake into apoptotic cells. Biotech. & Histochem. 86: 255–261.
  • Horobin RW (1982). Histochemistry: an Exploratory Outline of Histochemistry and Biophysical Staining. Gustav Fischer, New York. pp. 56–110, 24–256.
  • Horobin RW (2002). Biological staining: mechanisms and theory. Biotech. & Histochem. 77: 3–13
  • Horobin RW (2007a). Editor’s note. Biotech. & Histochem. 82: 47–49.
  • Horobin RW (2007b). Editorial note. Biotech. & Histochem. 82: 283–284.
  • Horobin RW (2011). How Romanowski stains work and why they remain valuable–including a proposed universal Romanowski staining mechanism and a rational troubleshooting scheme. Biotech. & Histochem. 86: 36–51.
  • Horobin RW (2012). Report on the 2nd Workshop on Fluorescence Chemosensors and Bioimaging, Dalian, China: one participant’s view. Biotech. & Histochem. 87: 69–71.
  • Horobin RW, Huff M (2009). Bibliography–R. W. Mowry. Biotech. & Histochem. 84: 35–36.
  • Horobin RW, Kiernan JA (2002). Conn’s Biological Stains: a Handbook of Dyes, Stains and Fluorochromes for Use in Biology and Medicine, 10th ed., BIOS Scientific Publishers, Oxford, UK. 555 pp.
  • Horobin RW, Rashid-Doubell F (2013). Predicting small-molecule fluorescent probe localization in living cells using QSAR modeling. 2. Specifying probe, protocol and cell factors; selecting QSAR models; predicting entry and localization. Biotech. & Histochem. 88: 461–476.
  • Horobin RW, Rashid-Doubell F, Pediani JD, Milligan G (2013). Predicting small-molecule fluorescent probe localization in living cells using QSAR modeling. 1. Overview, and models for probes of structure, properties and function in single cells. Biotech. & Histochem., 88: 440–460.
  • Huang JS, Egger ME, Grizzle WE, McNally LR (2013). MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells. Histochemistry 88: 397–402.
  • Ikeda R, Aiyama, Redman RS (2009). Exogenous thyroid hormone affects myoepithelium and proliferation in the developing rat parotid gland. Biotech. & Histochem. 84: 267–274.
  • Ingram M, Techy GB, Ward BR, Imam SA, Atkinson R, Ho H, Taylor CR (2010). Tissue engineered tumor models. Biotech. & Histochem. 85: 213–229.
  • Jones J, Grizzle W, Wang H, Yates C (2013). MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans. Biotech. & Histochem. 88: 410–424.
  • Jones ML (2007). How formalin affects the outcome of routine and special stains. Biotech. & Histochem. 82: 155–159.
  • Kasten FH (2003). Robert Feulgen and his histochemical reaction for DNA. Biotech. & Histochem. 78: 45–49.
  • Kiernan JA (2004). Hexazonium pararosaniline as a fixative for animal tissues. Biotech. & Histochem. 79: 203–210.
  • Kiernan JA (2007). Indigogenic substrates for detection and localization of enzymes. Biotech. & Histochem. 82: 73–103.
  • Kiernan JA (2008). Histological and Histochemical Methods: Theory and Practice, 4th ed. Scion Publishing Ltd., Oxfordshire, UK.
  • Kiernan JA (2009). A system for quantitative evaluation of fixatives for light microscopy using paraffin sections of kidney and brain. Biotech. & Histochem. 84: 1–10.
  • Kiernan JA, Horobin RW (2010). A special issue devoted to hematoxylin, hematein and hemalum. Biotech. & Histochem. 85: 5–6.
  • Kolts BR, Hicks DG, Whitney-Miller CL (2012). HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options. Biotech. & Histochem. 87: 40–45.
  • Krafts KP (2011). The Malachowski-Wright-Giemsa stain in the new millennium. Part 1 of special issue. Biotech. & Histochem. 86: 5–6.
  • Lillie RD (1977). H.J. Conn’s Biological Stains: a Handbook on the Nature and Uses of the Dyes Employed in the Biological Laboratory, 9th ed., Williams and Wilkins Co., Baltimore.
  • Lin Y, Hatem J, Wang J, Quinn A, Hicks DG, Tang P (2011). Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast. Biotech. & Histochem. 86: 345–350.
  • Longley JB (2009). Tribute to Bob Mowry. Biotech. & Histochem. 84: 31.
  • Lyon HO (2002). Dye purity and dye standardization for biological staining. Biotech. & Histochem. 77: 57–80.
  • Lyon HO (2012). News from the Biological Stain Commission. No. 12. Biotech. & Histochem. 87: 235–239.
  • Lyon HO (2013a). News from the Biological Stain Commission. No. 13. Biotech. & Histochem. 88: 54–58.
  • Lyon HO (2013b). News from the Biological Stain Commission. No. 14. Biotech. & Histochem. 88: 208–2012.
  • Lyon HO, Horobin RW (2007). Standardization and standards for dyes and stains used in biology and medicine. Biotech. & Histochem. 82: 1–11.
  • Lyon HO, Schulte EK, Prentø P, Barer MR, Béné M-C (2002). Standardized staining methods: Feulgen-Rossenbeck reaction for desoxyribonucleic acid and periodic acid–Schiff (PAS) procedure. Biotech. & Histochem. 77: 121–125.
  • Mackay M (2003). Traditional natural dyeing using crotal. Biotech. & Histochem. 78: 309–311.
  • McNally LR, Manne U, Grizzle WE (2013). Post-transcriptional processing of genetic information and its relation to cancer. Biotech. & Histochem. 88: 365–372.
  • Mowry RW (1980). Report from the President: the Biological Stain Commission: its goals, its past and its present status. Stain Technol. 55: 1–7.
  • Mowry RW, Kasten FW (1975). The importance of dye purification and standardization in biomedicine. Stain Technol. 50: 65–81.
  • Øresland V, Horobin RW (2012). Tracking living decapod larvae: mass staining of eggs with neutral red prior to hatching. Biotech. & Histochem. 87: 229–224.
  • Otali D, Stockard CR, Oelschlager DK, Wan W, Manne U, Watts SA, Grizzle WE (2009). The combined effects of formalin fixation and individual steps in tissue processing on immune-recognition. Biotech. & Histochem. 84: 223–247.
  • Otali D, He Q, Stockard CR, Grizzle WE (2013). Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% alcohol. Biotech. & Histochem. 88: 170–180.
  • Paliwal A, Srikantan S, De PK, Hand AR, Redman RS (2006). Histological and biochemical characterization of von Ebner’s glands in the Syrian hamster: comparison with rat von Ebner’s glands. Biotech. & Histochem. 81: 139–149.
  • Penney DP (2000). A brief history of the Biological Stain Commission: its founders, its mission and the first 75 years. Biotech. & Histochem. 75: 154–166.
  • Penney DP (2005). Revised bylaws of the Biological Stain Commission. Biotech. & Histochem. 80: 1–6.
  • Penney DP (2009) Robert W. Mowry, M.D.Some thoughts about his contributions to the Biological Stain Commission.Biotech. & Histochem. 84: 33–34.
  • Penney DP (2012a). Comments on the history of the Biological Stain Commission, Inc. Biotech. & Histochem. 87: 3–9.
  • Penney DP (2012b). Obituary: Charles Joseph Churukian. Biotech. & Histochem. 87: 68.
  • Penney DP, Powers JM, Frank M, Willis C, Churukian C (2002). Analysis and testing of biological stains—The Biological Stain Commission procedures. Biotech. & Histochem. 77: 237–275.
  • Penney DP, Frank M, Fagan C, Willis C (2009). Stain and dye stability over a 30-year period: a comparison of certified dye powders by the Biological Stain Commission. Biotech. & Histochem. 84: 11–15.
  • Prentø P (2001). A contribution to the theory of biological staining based on the principles for structural organization of biological macromolecules. Biotech. & Histochem. 76: 137–161.
  • Prentø P, Lyon HO (2003). Methyl green-pyronin Y staining of nucleic acids: studies on the effects of staining time, dye composition and diffusion rates. Biotech. & Histochem. 78: 27–33.
  • Redman RS (2008). On approaches to the functional restoration of salivary glands damaged by radiation therapy for head and neck cancer, with a review of related aspects of salivary gland morphology and development. Biotech. & Histochem. 83: 103–130.
  • Redman RS (2012). Morphological diversity of the minor salivary glands of the rat: fertile ground for studies in gene function and proteomics. Biotech. & Histochem. 87: 273–287.
  • Redman RS, Jelic JS, Kruse DH, Wilkins SD, Field RB (2002). An enzyme histochemical and biochemical study of the activity of three oxidative enzymes in the developing rat parotid gland. Biotech. & Histochem. 77: 189–200.
  • Redman RS, Ball WD, Mezey É, Key S (2009). Dispersed donor salivary gland cells are widely distributed in the recipient gland when infused up the ductal tree. Biotech. & Histochem. 84: 253–260.
  • Rodriguez-Burford C, Oelschlager DK, Talley LI, Barnes MN, Partridge EE, Grizzle WE (2003). The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines. Biotech. & Histochem. 78: 17–21.
  • Sabatino L, Scordino M, Gargano M, Lazzaro F, Borzi MA (2012). Aminocarminic acid in E120-labelled food additives and beverages. Food Add. Contam. Part B 2012: 1–6.
  • Shanmugam C, Katkoori VR, Jhala NC, Grizzle WE, Manne U (2009). Immunohistochemical expression of rabphilin-3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas. Biotech. & Histochem. 84: 39–45.
  • Shi JX, Liang QQ, Wang YJ, Mooney RA, Boyce BF, Xing L (2013). Use of a whole-slide imaging system to assess the presence and alteration of lymphatic vessels in joint sections of arthritic mice. Biotech. & Histochem. 88: 428–439.
  • Shi S-R, Taylor CR (2010). Antigen Retrieval Immunohistochemistry Based Research and Diagnostics. John Wiley & Sons, Inc., Hoboken, NJ.
  • Shi S-R, Liu C, Young L, Taylor CR (2007). Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods. Biotech. & Histochem. 82: 301–309.
  • Srivastava SK, Bhardwaj A, Leavesley SJ, Grizzle WE, Singh S, Singh AP (2103). MicroRNAs as potential clinical biomarkers: emerging approaches for their detection. Biotech. & Histochem. 88: 373–387.
  • Stockert JC, Abasolo MI, Blazquez-Castro, Horobin RW, Revilla M, Lombardo DM (2010). Selective labeling of lipid droplets in aldehyde fixed cell monolayers by lipophilic fluorochromes. Biotech. & Histochem. 85: 277–283.
  • Talley LI, Chhieng DC, Bell WC, Grizzle WE, Frost AR (2008). Immunohistochemical detection of EGFR, p185erbB-2, Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women. Biotech. & Histochem. 83: 5–14.
  • Thompson K, Dockery P, Horobin RW (2012). Predicting and avoiding subcellular compartmentalization artifacts arising from acetoxymethyl ester calcium imaging probes. The case of fluo-3 AM and a general account of the phenomenon including a problem avoidance chart. Biotech. & Histochem. 87: 468–483.
  • Wainwright M (2003). Orcein, a traditional stain revealed: some introductory remarks. Biotech. & Histochem. 78: 285–287.
  • Wang D, Stockard CR, Harkins L, Lott P, Salih C, Yuan K, Buchsbaum D, Hashim A, Zayzafoon M, Hardy RW, Hameed O, Grizzle W, Siegal GP (2008). Immunohistochemistry in the evaluation of neovascularization in tumor xenografts. Biotech. & Histochem. 83: 179–189.
  • Wittekind D (2003). Traditional staining for routine diagnostic pathology including the role of tannic acid. 1. Value and limitations of the hematoxylin-eosin stain. Biotech. & Histochem. 78: 261–270.
  • Zhang H-G, Zhuang X, Sun D, Liu Y, Xiang X, Grizzle WE (2012). Exosomes and immune surveillance of neoplastic lesions: a review. Biotech. & Histochem. 87: 161–167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.